LifeVantage Corp. (LFVN)
5.61
+0.24
(+4.47%)
USD |
NASDAQ |
May 22, 16:00
5.58
-0.03
(-0.53%)
After-Hours: 20:00
LifeVantage Research and Development Expense (Annual) : 1.40M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Niagen Bioscience, Inc. | 6.33M |
| Nature's Sunshine Products, Inc. | 1.90M |
| AXIL Brands, Inc. | -- |
| Cyanotech Corp. | 0.449M |
| Herbalife Ltd. | -- |